Walleye Capital’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$595K Sell
51,900
-59,700
-53% -$841K ﹤0.01% 2517
2025
Q4
$1.6M Sell
111,600
-81,400
-42% -$1.41M ﹤0.01% 2043
2025
Q3
$3.65M Buy
193,000
+75,600
+64% +$1.25M 0.01% 1129
2025
Q2
$2.52M Buy
117,400
+91,400
+352% +$1.36M 0.01% 1341
2025
Q1
$341K Sell
26,000
-387,100
-94% -$5.75M ﹤0.01% 2859
2024
Q4
$5.55M Buy
413,100
+380,700
+1,175% +$6.13M 0.01% 1004
2024
Q3
$687K Sell
32,400
-189,200
-85% -$3.41M ﹤0.01% 3006
2024
Q2
$3.51M Buy
221,600
+203,800
+1,145% +$3.75M 0.01% 1577
2024
Q1
$265K Buy
17,800
+13,000
+271% +$178K ﹤0.01% 3762
2023
Q4
$43.9K Buy
+4,800
New +$33.1K ﹤0.01% 4335

Other funds holding OSCR

Walleye Capital's OSCR Position: Q1 2026 in Review

Walleye Capital reduced its Oscar Health (OSCR) stake by 67% in Q1 2026, selling an estimated $1.61M and leaving 57,215 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #2437.

Walleye Capital first reported a position in OSCR in Q1 2022 and has held it in 11 quarters since. The position peaked at $4.13M in Q3 2025. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Walleye Capital held 57,215 shares of Oscar Health worth $656K as of Q1 2026.
  • Walleye Capital sold 114,437 Oscar Health shares in Q1 2026, an estimated $1.61M.
  • Oscar Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2437 holding.
  • Walleye Capital first reported a position in Oscar Health in Q1 2022 and has held it in 11 quarters since.
  • Walleye Capital's Oscar Health position peaked at $4.13M in Q3 2025.
  • 330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.